A Pilot Study of PLX3397 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients With Bone Metastasis and High Circulating Tumor Cell (CTC) Counts
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007342/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The main objective of this study is to evaluate the effects of PLX3397 on male subjects with
CRPC.
Secondary objectives include evaluating the safety and tolerability of PLX3397 and the
anti-tumor effects that PLX3397 has on the the subjects.
本研究的主要目标为评估PLX3397对去势抵抗性前列腺癌（Castration-Resistant Prostate Cancer, CRPC）男性受试者的作用效果。次要研究目标包括评估PLX3397的安全性与耐受性，以及该药物对受试者的抗肿瘤效应。
提供机构：
Vivli
创建时间：
2021-08-24
